This isn’t toxic though, literally 95% of Capital raises on the NYSE and NASDAQ for bio’s and other companies come from private investments or direct offerings where insitiutions or individuals will buy shares at a discount or incentive... this is always a better option than taking out notes which have interest and can dilute anytime.